Cargando…
Return to ovulation after Sayana Press is injected every 4 months for one year: Empirical and pharmacokinetic/pharmacodynamic modeling results()
OBJECTIVE: To characterize return to ovulation after injecting Sayana Press (104 mg/0.65 mL medroxyprogesterone acetate [MPA] in the Uniject device) every 4 months for 1 year of treatment. STUDY DESIGN: We followed a subset of women for return to ovulation in a trial that demonstrated Sayana Press r...
Autores principales: | Taylor, Douglas J., Deese, Jennifer, Bahamondes, Luis, Brache, Vivian, Veiga, Nelio, Fuchs, Rachael, Halpern, Vera, Dorflinger, Laneta J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372597/ https://www.ncbi.nlm.nih.gov/pubmed/35965654 http://dx.doi.org/10.1016/j.conx.2022.100080 |
Ejemplares similares
-
Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial
por: Deese, Jennifer, et al.
Publicado: (2022) -
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
por: Taylor, Douglas J., et al.
Publicado: (2022) -
Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trial
por: Halpern, Vera, et al.
Publicado: (2021) -
Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera
por: Halpern, Vera, et al.
Publicado: (2021) -
Pilot Research as Advocacy: The Case of Sayana Press in Kinshasa, Democratic Republic of the Congo
por: Binanga, Arsene, et al.
Publicado: (2016)